- Home
- AQST vs LOCO Comparison
AQST vs LOCO Comparison
Compare AQST & LOCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AQST | LOCO |
|---|---|---|
| Founded | 2004 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 529.4M | 456.5M |
| IPO Year | 2007 | 2014 |
Fundamental Metrics
Financial Performance| Metric | AQST | LOCO |
|---|---|---|
| Price | $4.77 | $15.17 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 4 |
| Target Price | $9.00 | ★ $14.17 |
| AVG Volume (30 Days) | ★ 3.4M | 194.5K |
| Earning Date | 05-01-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 4.65 |
| EPS | N/A | ★ 0.70 |
| Revenue | $67,430,000.00 | ★ $401,701,000.00 |
| Revenue This Year | $10.08 | $3.60 |
| Revenue Next Year | $49.60 | $3.98 |
| P/E Ratio | ★ N/A | $21.51 |
| Revenue Growth | 0.77 | ★ 5.68 |
| 52 Week Low | $2.94 | $8.99 |
| 52 Week High | $7.55 | $17.40 |
Technical Indicators
Market Signals| Indicator | AQST | LOCO |
|---|---|---|
| Relative Strength Index (RSI) | 55.64 | 43.15 |
| Support Level | $4.03 | $13.52 |
| Resistance Level | $5.10 | $15.75 |
| Average True Range (ATR) | 0.26 | 0.41 |
| MACD | -0.02 | -0.02 |
| Stochastic Oscillator | 48.53 | 13.57 |
Price Performance
Historical ComparisonAbout AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
About LOCO El Pollo Loco Holdings Inc.
El Pollo Loco Holdings Inc operates and franchises hundreds of fast-casual chicken restaurants in the United States. It specializes in fire-grilling citrus-marinated chicken and operates in the limited service restaurant market segment. Its offerings include Mexican-inspired menu items, including burritos, tostadas, bowls, salads, and bone-in chicken meals in various portion sizes. It also offers citrus-marinated fire-grilled chicken, along with a range of salsas and dressings that allow customers to customize their meals. The company operates in one operating segment. The majority of the company's revenue is derived from company-operated restaurant revenue.